Q2 2026 Holdings
Filed 2026-08-13 | 43 holdings | $635.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Uipath Inc(PATH) | CL A | 90364P105 | $336.4M | 30,950,000 | 53.0% |
| Kolibri Global Energy Inc(KGEI) | COM NEW | 50043K406 | $33.8M | 6,834,504 | 5.3% |
| Autolus Therapeutics LTD(AUTL) | SPON ADS | 05280R100 | $15.2M | 9,500,000 | 2.4% |
| Lyft Inc(LYFT) | CL A COM | 55087P104 | $14.6M | 1,000,000 | 2.3% |
| Definium Therapeutics Inc(DFTX) | COM SHS | 24477V105 | $13.5M | 286,990 | 2.1% |
| Workiva Inc(WK) | COM CL A | 98139A105 | $12.1M | 250,000 | 1.9% |
| Sprinklr Inc(CXM) | CL A | 85208T107 | $11.4M | 2,200,000 | 1.8% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $11.2M | 203,543 | 1.8% |
| Alkami Technology Inc(ALKT) | COM | 01644J108 | $10.9M | 600,284 | 1.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $10.8M | 290,441 | 1.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $10.7M | 570,311 | 1.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $10.6M | 130,484 | 1.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $10.2M | 295,627 | 1.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $10.0M | 189,979 | 1.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $9.9M | 255,934 | 1.6% |
| Axsome Therapeutics Inc.(AXSM)Call | COM | 05464T104 | $8.6M | 35,000 | 1.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $8.4M | 764,256 | 1.3% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.9M | 356,657 | 1.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.7M | 97,173 | 1.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $7.6M | 205,579 | 1.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $7.3M | 201,036 | 1.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $7.3M | 19,668 | 1.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $7.1M | 1,242,455 | 1.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $6.7M | 64,110 | 1.1% |
| Warner Bros Discovery Inc(WBD) | COM SER A | 934423104 | $6.7M | 250,000 | 1.0% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $6.1M | 86,996 | 1.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $5.4M | 297,926 | 0.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.2M | 167,875 | 0.7% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $3.3M | 100,000 | 0.5% |
| Silence Therapeutics PLC(SLN)Call | ADS | 82686Q101 | $3.3M | 300,000 | 0.5% |
| CUE Biopharma Inc(CUE) | COM | 22978P205 | $3.0M | 93,819 | 0.5% |
| Snowflake Inc(SNOW) | COM SHS | 833445109 | $2.5M | 10,000 | 0.4% |
| Karyopharm Therapeutics Inc(KPTI)Call | COM NEW | 48576U205 | $2.4M | 250,300 | 0.4% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.1M | 400,000 | 0.3% |
| Agios Pharmaceuticals Inc(AGIO)Call | COM | 00847X104 | $1.9M | 50,000 | 0.3% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $1.6M | 46,516 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $1.4M | 56,052 | 0.2% |
| Tenax Therapeutics Inc(TENX)Call | COM NEW | 88032L605 | $1.1M | 75,100 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX)Call | COM | 03237H101 | $152.7K | 8,500 | 0.0% |